Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer

Clinical trial NCT04974879 · UNKNOWN

Trial details

NCT number: NCT04974879
Sponsor: Qingdao Central Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2021-07-01
Primary completion: 2024-07-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.